Latest News- Epigenetics Market: Oncology is expected to lead the Application segment during 2024-2028

The Epigenetics Market is being driven by Rising epigenetic applications in non-oncology diseases

The Epigenetics Market is expected to grow at a CAGR of 14.75% during 2023 and 2028. During this period, the market is also expected to show a growth of USD 1477.78 million. The epigenetics market is experiencing significant growth in the life sciences sector, driven by the rising prevalence of chronic diseases and the demand for personalized medicine. Enzyme technology, a key area of advancement, involves the production, isolation, and utilization of enzymes, whether in soluble or immobilized form, for the synthesis of drugs, peptides, and proteins. Researchers are engineering enzymes to modify their properties, such as kinetics, thermal stability, solvent compatibility, and reaction specificity, to enhance their functionality in gene expression studies. This technology is also utilized in the pharmaceutical industry to create drugs addressing conditions like spinal injuries, nerve tissue regeneration, and severe combined immunodeficiency (SCID).

Get more information on Epigenetics Market by requesting a sample report

Which Factors Are Causing a Surge in Market Growth?

The market is segmented based on

Application
- Oncology
- Non-oncology
- Cardiovascular Diseases
- Developmental Biology
- Immunology
- Metabolic Diseases
Product
- Reagents
- Kits
- Enzymes
- Instruments
- Software
- Services
- others
Technology
- DNA Methylation
- Histone Methylation
- Histone Acetylation
- Large non-coding RNA
- MicroRNA modification
- Chromatin structures
- Bisulfite Sequencing
- Next-Generation Sequencing (NGS)
- PCR-based Methods
- Chromatin Remodeling
End-Use
- Academic Research
- Clinical Research
- Hospitals & Clinics
- Pharmaceutical & Biotechnology Companies
- Other
- Contract Research Organizations (CROs)
- Diagnostic Laboratories
- Academic Research
- Clinical Research
- Hospitals & Clinics
- Pharmaceutical & Biotechnology Companies
- Other Users
Geography
- North America
  - Canada
  - US
- Europe
  - Germany
  - UK
  - Netherlands
- Asia
  - China
  - Japan
  - South Korea
- Rest of World (ROW)

According to Technavio, There are several factors that are causing the market to flourish during the forecast period, which are as follows:

Rising epigenetic applications in non-oncology diseases
Increasing prevalence of CVDs
Rising strategic collaboration among vendors

However, the market also witnesses some limitations, which are as follows:

Lack of clinical validation on direct-to-consumer genetic tests
Privacy issues concerning data leakage of genetic information
Unfavorable reimbursement scenario associated with genetic testing

Benefits of Buying Global Epigenetics Market Research Report by Technavio

Rich Experience: 20+ years leading global market research, trusted insights across industries.

Unlock Business Potential with Technavio: Maximize ROI with Technavio's tailored market research: deep dives and actionable insights.

Your Guide to Market Success: Empower your business with Technavio's market research and future-proof your decisions.

Market Scope in Epigenetics Market Research Report

Market Scope
Report Coverage	Details
Page number	163
Base year	2023
Historic period	2018-2022
Forecast period	2024-2028
Growth momentum & CAGR	Accelerate at a CAGR of 14.75%
Market growth 2024-2028	USD 1477.78 million
Market structure	market_structure.ucfirst
YoY growth 2023-2024(%)	13.54
Key countries	US, Canada, Germany, UK, China, Japan, South Korea, Netherlands, UAE, Brazil, Rest of World(ROW), US, Canada, Germany, UK, and China
Competitive landscape	Leading Companies, Market Positioning of Companies, Competitive Strategies, and Industry Risks

Request Free Sample

Find out which segment is leading the market by accessing the free PDF report

Research Analysis Overview

The Epigenetics Market encompasses various aspects of epigenetics research, including Epigenome Mapping to understand the intricate Epigenetic Landscape, Epigenetic Reprogramming for cellular transformation, and Epigenetic Memory retention. Epigenetic Alterations, Dysregulation, and Instability lead to diseases, necessitating the development of Epigenetic Therapy through Engineering, Therapy Development, and Clinical Trials. Epigenetic Biomarker Discovery, Validation, and Application are crucial for Diagnosis and Prognosis. Epigenetic Data Integration, Interpretation, Machine Learning, and Artificial Intelligence facilitate advanced Epigenetic Bioinformatics, Computational Biology, Systems Biology, Network Analysis, and Pathway Analysis. Epigenetic Ontology, Knowledge Graph, Collaboration, Consortium, Open Science, Public Databases, and Public Datasets foster research advancement and Public Awareness. Epigenetic Modifiers, Inhibitors, Activators, and Modulators are essential tools for Epigenetic Research. Epigenetic Drug Safety, Efficacy, and Resistance are critical factors for Drug Development.

Market Research Overview

The epigenetics market is a significant segment of the global life sciences tools and services industry, as identified by Technavio. This market encompasses companies and products involved in the research, development, and application of Epigenetic Modification, Epigenetic Profiling, Epigenetic Testing, Epigenetic Drugs, Epigenetic Biomarkers, and Epigenetic Therapies. These innovations fall under the broader umbrella of the life sciences tools and services market, which includes manufacturers of equipment, supplies, pharmaceuticals, biotechnology, and contract research services. Technavio's market analysis calculates the global healthcare market size based on the combined revenue generated from these various sectors.. Industries are leveraging the products belonging to the market for customer engagement, transactional notifications, and promotional offers.

Contacts

Technavio Research
Jesse Maida
Media & Marketing Executive
US: +1 844 364 1100
UK: +44 203 893 3200
Email: media@technavio.com
Website: www.technavio.com/

Read News Read Less